Oxford Drug Design
Biotechnology company with a proprietary computational and machine learning platform
Oxford, UKwww.oxforddrugdesign.com ↗
Total raised
€2.6M
€2,596,719
Funding rounds
1
Investors
4
distinct backers
Active since
2022-05
latest 2022-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood11
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-05-19 | Other | €2.6M | ACF investors,Meltwind Advisory,o2h Ventures,R42 Group | View deal → |
Related news
- Cancer-fighting spinout Oxford Drug Design raises £2.2mbusinesscloud.co.uk · 2022-05